ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Temporal trends in Hematopoietic Stem Cell Transplantation in Argentina. [Editorial]: regional differences that mirror the global reality (2023)
Rego, Eduardo M.
Source: Hematology transfusion and cell therapy. Unidade: FM
Subjects: CÉLULAS-TRONCO, TRANSPLANTE AUTÓLOGO, ARGENTINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REGO, Eduardo M. Temporal trends in Hematopoietic Stem Cell Transplantation in Argentina. [Editorial]: regional differences that mirror the global reality. Hematology transfusion and cell therapy. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/54553. Acesso em: 07 nov. 2024. , 2023
APA
Rego, E. M. (2023). Temporal trends in Hematopoietic Stem Cell Transplantation in Argentina. [Editorial]: regional differences that mirror the global reality. Hematology transfusion and cell therapy. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.htct.2023.05.001
NLM
Rego EM. Temporal trends in Hematopoietic Stem Cell Transplantation in Argentina. [Editorial]: regional differences that mirror the global reality [Internet]. Hematology transfusion and cell therapy. 2023 ; 45( 2): 145-146.[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54553
Vancouver
Rego EM. Temporal trends in Hematopoietic Stem Cell Transplantation in Argentina. [Editorial]: regional differences that mirror the global reality [Internet]. Hematology transfusion and cell therapy. 2023 ; 45( 2): 145-146.[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54553
Artigo de periodico
Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia (2022)
Lima, Keli ; Pereira-Martins Diego A. ; Miranda, Lívia Bassani Lins de ; Coelho-Silva, Juan L. ; Leandro, Giovana da Silva ; Isabel Weinhäuser ; Cavaglieri, Rita de Cássia ; Silva, Wellington F.; Leal, Aline Medeiros; Lange, Ana Paula Alencar de Lima; Velloso, Elvira Deolinda Rodrigues Pereira ; Griessinger, Emmanuel ; Hilberink, Jacobien R. ; Huls, Gerwin A. ; Schuringa, Jan Jacob ; Rego, Eduardo M. ; Machado Neto, João Agostinho
Source: Blood. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, NEOPLASIAS POR TIPO HISTOLÓGICO, AMINOÁCIDOS, PROTEÍNAS QUINASES, DANO AO DNA, MITOCÔNDRIAS, HOMEOSTASE, LISOSSOMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli et al. Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia. Blood, v. 140, p. 5965–5966, 2022Tradução . . Disponível em: https://doi.org/10.1182/blood-2022-165172. Acesso em: 07 nov. 2024.
APA
Lima, K., Pereira-Martins Diego A.,, Miranda, L. B. L. de, Coelho-Silva, J. L., Leandro, G. da S., Isabel Weinhäuser,, et al. (2022). Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia. Blood, 140, 5965–5966. doi:10.1182/blood-2022-165172
NLM
Lima K, Pereira-Martins Diego A., Miranda LBL de, Coelho-Silva JL, Leandro G da S, Isabel Weinhäuser, Cavaglieri R de C, Silva WF, Leal AM, Lange APA de L, Velloso EDRP, Griessinger E, Hilberink JR, Huls GA, Schuringa JJ, Rego EM, Machado Neto JA. Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia [Internet]. Blood. 2022 ; 140 5965–5966.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1182/blood-2022-165172
Vancouver
Lima K, Pereira-Martins Diego A., Miranda LBL de, Coelho-Silva JL, Leandro G da S, Isabel Weinhäuser, Cavaglieri R de C, Silva WF, Leal AM, Lange APA de L, Velloso EDRP, Griessinger E, Hilberink JR, Huls GA, Schuringa JJ, Rego EM, Machado Neto JA. Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia [Internet]. Blood. 2022 ; 140 5965–5966.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1182/blood-2022-165172
Artigo de periodico
The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells (2021)
Almeida, Luciana Yamamoto de; Martins, Diego A. Pereira; Weinhäuser, Isabel; Ortiz, César; Cândido, Larissa A.; Lange, Ana Paula; Abreu, Nayara F. de; Mendonza, Sílvia E. S.; Wagatsuma, Virgínia M. de Deus; Nascimento, Mariane C. do; Paiva, Helder H.; Alves-Paiva, Raquel M.; Bonaldo, Camila C. O. M.; Nascimento, Daniele C.; Alves-Filho, José Carlos; Scheucher, Priscila S.; Lima, Ana Silvia Gouvêa de; Schuringa, Jan Jacob; Ammantuna, Emanuele; Ottone, Tiziana; Noguera, Nelida I.; Araujo, Cleide L.; Rego, Eduardo M.
Source: Frontiers in Oncology. Unidades: FMRP, FM
Subjects: LEUCEMIA, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Luciana Yamamoto de et al. The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells. Frontiers in Oncology, v. 11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fonc.2021.686445. Acesso em: 07 nov. 2024.
APA
Almeida, L. Y. de, Martins, D. A. P., Weinhäuser, I., Ortiz, C., Cândido, L. A., Lange, A. P., et al. (2021). The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells. Frontiers in Oncology, 11. doi:10.3389/fonc.2021.686445
NLM
Almeida LY de, Martins DAP, Weinhäuser I, Ortiz C, Cândido LA, Lange AP, Abreu NF de, Mendonza SES, Wagatsuma VM de D, Nascimento MC do, Paiva HH, Alves-Paiva RM, Bonaldo CCOM, Nascimento DC, Alves-Filho JC, Scheucher PS, Lima ASG de, Schuringa JJ, Ammantuna E, Ottone T, Noguera NI, Araujo CL, Rego EM. The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells [Internet]. Frontiers in Oncology. 2021 ; 11[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fonc.2021.686445
Vancouver
Almeida LY de, Martins DAP, Weinhäuser I, Ortiz C, Cândido LA, Lange AP, Abreu NF de, Mendonza SES, Wagatsuma VM de D, Nascimento MC do, Paiva HH, Alves-Paiva RM, Bonaldo CCOM, Nascimento DC, Alves-Filho JC, Scheucher PS, Lima ASG de, Schuringa JJ, Ammantuna E, Ottone T, Noguera NI, Araujo CL, Rego EM. The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells [Internet]. Frontiers in Oncology. 2021 ; 11[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fonc.2021.686445
Trabalho de evento-resumo periodico
De-n-acetyl-GD3 ganglioside, a novel derivative of the tumor-associated antigen GD3, is expressed in normal lymphocytes (2001)
Chammas, Roger; Rego, Eduardo M.; Palma, Patricia; Covas, Dimas T.; Falcão, Roberto P.; Zago, Marco A.
Source: Blood (Journal of The American Society of Hematology). Conference titles: American Society of Hematology Annual Meeting. Unidades: FM, FMRP
Subjects: LINFÓCITOS, GÂNGLIOS, HEMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAMMAS, Roger et al. De-n-acetyl-GD3 ganglioside, a novel derivative of the tumor-associated antigen GD3, is expressed in normal lymphocytes. Blood (Journal of The American Society of Hematology). Washington: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 07 nov. 2024. , 2001
APA
Chammas, R., Rego, E. M., Palma, P., Covas, D. T., Falcão, R. P., & Zago, M. A. (2001). De-n-acetyl-GD3 ganglioside, a novel derivative of the tumor-associated antigen GD3, is expressed in normal lymphocytes. Blood (Journal of The American Society of Hematology). Washington: Faculdade de Medicina, Universidade de São Paulo.
NLM
Chammas R, Rego EM, Palma P, Covas DT, Falcão RP, Zago MA. De-n-acetyl-GD3 ganglioside, a novel derivative of the tumor-associated antigen GD3, is expressed in normal lymphocytes. Blood (Journal of The American Society of Hematology). 2001 ; 98( 11): 33b.[citado 2024 nov. 07 ]
Vancouver
Chammas R, Rego EM, Palma P, Covas DT, Falcão RP, Zago MA. De-n-acetyl-GD3 ganglioside, a novel derivative of the tumor-associated antigen GD3, is expressed in normal lymphocytes. Blood (Journal of The American Society of Hematology). 2001 ; 98( 11): 33b.[citado 2024 nov. 07 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Indexado em

Non normalized affiliation